SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-85087"
 

Search: onr:"swepub:oai:DiVA.org:liu-85087" > Virtual Histology A...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus—Results of a Multicenter Trial

Arora, Satish (author)
Oslo University Hospital Rikshospitalet, Norway,Rigshospitalet, Copenhagen, Denmark
Erikstad, I. (author)
Oslo University Hospital Rikshospitalet, Norway
Ueland, T. (author)
Oslo University Hospital Rikshospitalet, Norway
show more...
Sigurdardottir, V. (author)
Sahlgrenska University Hospital, Gothenburg, Sweden
Ekmehag, Björn (author)
Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital and Lund University, Lund, Sweden
Jansson, Kjell (author)
Östergötlands Läns Landsting,Linköpings universitet,Kardiologi,Hälsouniversitetet,Kardiologiska kliniken US
Eiskjaer, H. (author)
Östergötlands Läns Landsting,Kardiologiska kliniken US,Skejby University Hospital, Denmark
Bøtker, H. E. (author)
Skejby University Hospital, Denmark
Mortensen, S.-A. (author)
Rigshospitalet, Copenhagen, Denmark
Saunamaki, K. (author)
Rigshospitalet, Copenhagen, Denmark
Gude, E. (author)
Oslo University Hospital Rikshospitalet, Norway
Ragnarsson, A. (author)
Oslo University Hospital Rikshospitalet, Norway
Solbu, D. (author)
Medical Department, Novartis, Norway
Gullestad, L (author)
Oslo University Hospital Rikshospitalet, Norway
Jansson, Kristina (author)
Lund University,Lunds universitet,Klinisk mikrobiologi, Malmö,Forskargrupper vid Lunds universitet,Clinical Microbiology, Malmö,Lund University Research Groups
Aukrust, P (author)
show less...
 (creator_code:org_t)
Wiley-Blackwell, 2012
2012
English.
In: American Journal of Transplantation. - : Wiley-Blackwell. - 1600-6135 .- 1600-6143. ; 12:10, s. 2700-2709
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • In this 12-month multicenter Scandinavian study, 78 maintenance heart transplant (HTx) recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) exposure or continued standard CNI-therapy underwent matched virtual histology (VH) examination to evaluate morphological progression of cardiac allograft vasculopathy (CAV). Parallel measurement of a range of inflammatory markers was also performed. A similar rate of quantitative CAV progression was observed in the everolimus (n = 30) and standard CNI group (n = 48) (plaque index 1.9 +/- 3.8% and 1.6 +/- 3.9%, respectively; p = 0.65). However, VH analysis revealed a significant increase in calcified (2.4 +/- 4.0 vs. 0.3 +/- 3.1%; p = 0.02) and necrotic component (6.5 +/- 8.5 vs. 1.1 +/- 8.6%; p = 0.01) among everolimus patients compared to controls. The increase in necrotic and calcified components was most prominent in everolimus patients with time since HTx andgt;5.1 years and was accompanied by a significant increase in levels of von Willebrand (vWF) factor (p = 0.04) and vascular cell adhesion molecule (VCAM) (p = 0.03). Conversion to everolimus and reduced CNI is associated with a significant increase in calcified and necrotic intimal components and is more prominent in patients with a longer time since HTx. A significant increase in vWF and VCAM accompanied these qualitative changes and the prognostic implication of these findings requires further investigation.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)

Keyword

Cardiac allograft vasculopathy
everolimus
inflammation
virtual histology
MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view